Alpek Earnings Call: Cash Focus Amid Tough Cycle

Alpek SAB de CV Class A ((MX:ALPEKA)) has held its Q4 earnings call. Read on for the main highlights of the call.

Alpek’s latest earnings call struck a cautious but not pessimistic tone, as management balanced a sharp earnings decline and elevated leverage with improving free cash flow, active refinancing, cost-cutting and portfolio moves. The message to investors was that while industry headwinds remain serious, the company is increasingly focused on cash generation and deleveraging rather than growth at any cost.

Strong Free Cash Flow Recovery

Operational free cash flow rebounded strongly, reaching $163 million for the year, a 57% jump versus the prior period. Management credited tighter working capital management and disciplined capital allocation, signaling a clear shift toward protecting liquidity and funding debt reduction instead of aggressive expansion.

Corporate Simplification Completed

The company finalized its spin-off and merger with Controladora Alpek, leaving Alpek as a fully independent entity. This streamlined structure is meant to reduce complexity, sharpen accountability and help investors better track performance, which could eventually support a higher valuation once fundamentals stabilize.

Cash and Balance Sheet Management

Net debt closed the year at $1.8 billion, flat quarter-on-quarter but $44 million lower than in 2024, reflecting early deleveraging progress. Alpek also refinanced portions of its debt stack and kept committed credit lines in place, strengthening liquidity in case the industry downturn lasts longer than expected.

Footprint Optimization for 2026 Gains

Alpek shut PET operations at its Cedar Creek site and shifted that capacity to larger, more efficient plants in its network. Management expects this footprint optimization to deliver around $20 million of benefits in 2026, supporting margins without requiring major new capital spending.

Plastics & Chemicals Show Sequential Improvement

The Plastics & Chemicals segment posted comparable EBITDA of $55 million, up 17% sequentially, even though it remains about 50% below last year’s level. Stable reference margins helped offset lower volumes, suggesting some operational resilience despite weak demand and additional capacity in the market.

Disciplined CapEx and Lower 2026 Spending

Capital expenditures were tightly controlled at $51 million in the quarter and $170 million for the year, reflecting a cautious stance. For 2026, Alpek guided CapEx down to $130 million, prioritizing maintenance and selective strategic projects while preserving cash for debt reduction.

New Operating Free Cash Flow Metric

For the first time, Alpek issued operating free cash flow guidance, setting a 2026 range of $100 million to $150 million. Introducing this metric emphasizes management’s focus on cash generation and offers investors a clearer lens on the company’s ability to deleverage even in a tough margin environment.

Asset Monetization Pipeline for Deleveraging

Alpek has four U.S. properties in advanced stages of sale that could bring in roughly $50 million, most likely during the first half of 2026. These proceeds are earmarked for debt reduction, adding another lever to improve the balance sheet without relying solely on operating performance.

Reasonable but Cautious 2026 EBITDA Outlook

Management set a base-case 2026 comparable EBITDA range of $450 million to $500 million, broadly in line with current depressed levels. They also outlined potential upside of about $50 million if PET margins, freight, FX and tariffs move favorably, though this scenario is not embedded in the official guidance.

Sharp Full-Year EBITDA Contraction

Full-year comparable EBITDA dropped 30% to $489 million, underscoring the severity of the current downcycle. The decline reflects global overcapacity and particularly weak polyester margins, which have compressed profitability across much of Alpek’s portfolio.

Polyester Segment Under Significant Pressure

Polyester comparable EBITDA slid to $41 million, down 53% versus the third quarter, highlighting the segment’s vulnerability. Volumes fell to 836,000 tons, a 10% sequential and year-on-year decline as softer demand and extended maintenance shutdowns weighed heavily on utilization.

Broad-Based Volume Decline

Total segment volume came in at 1.02 million tons, down 9% versus both the previous quarter and the prior year. This broad-based weakness signals that end markets are soft across regions and products, limiting Alpek’s ability to offset price and margin pressure with higher throughput.

EBITDA Hit by Inventory and Commodity Moves

Reported quarterly EBITDA dropped 40% to $70 million, with a $29 million negative inventory adjustment adding to the pain. Falling commodity prices, including a 7% sequential drop in paraxylene, forced Alpek to mark down inventory, compressing reported earnings despite underlying cash measures.

Leverage Remains Elevated

Net leverage ended the period at 4.4 times net debt to EBITDA, or around 3.9 times on a pro forma basis adjusting for certain items. This remains well above the long-term target of 2.5 times, though management expects leverage to gradually settle near 3.5 times over the next 12 to 18 months if cash generation improves.

Industry Headwinds Likely to Persist

Executives warned that global oversupply, soft demand and low ocean freight rates will continue to pressure polyester and plastics margins into 2026. Plastics & Chemicals profitability is also expected to stay constrained by new North American capacity and weak EPS demand, limiting near-term earnings recovery.

Dividend Suspension and Ongoing Cost Actions

To preserve financial flexibility, Alpek has suspended its dividend, redirecting cash toward debt reduction and strategic initiatives. The company also continues cost-cutting and asset monetization efforts, emphasizing that deleveraging and portfolio optimization now outrank shareholder distributions.

Operational Disruptions Weighed on Results

Several planned maintenance outages ran longer than expected during 2025, especially in the polyester operations, further reducing volumes. These disruptions compounded already weak demand, but management suggested that the most significant outages are now behind them, pointing to more normalized operations ahead.

Forward Guidance and Deleveraging Roadmap

Alpek’s 2026 guidance assumes comparable EBITDA of $450 million to $500 million on about 4.5 million tons of volume, PET margins around $145 per ton and CapEx of $130 million. Management expects operating free cash flow of $100 million to $150 million and aims to stabilize leverage near 3.5 times, with potential EBITDA upside of roughly $50 million and about $50 million from U.S. property sales to accelerate deleveraging.

The earnings call painted a picture of a company navigating a difficult industry cycle while pulling every available lever to protect its balance sheet. Investors will likely view Alpek as a disciplined operator in a tough market, with the near-term story centered on cash, costs and deleveraging rather than growth until supply-demand conditions improve.